BackCARGO Therapeutics Overview

CARGO Therapeutics Receivables

CARGO Therapeutics's receivables is $800K.

Get informed when a big investor buys or sells

+ Follow
Receivables
$802000.00
↓ 68.11% YoYΔ $-1.71M vs prior year quarter

Peer average

Loading

CARGO Therapeutics Receivables History

Loading

CARGO Therapeutics vs. peers: Receivables Comparison

Loading

CARGO Therapeutics Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

CARGO Therapeutics (CRGX) FAQ

The latest receivables for CRGX is $800K as of June 2025. That compares with $2.5M in the prior-year period — down 68.1% year over year. Investors often review this figure alongside CARGO Therapeutics's historical trend and sector peers before judging valuation or financial health.

Over the past year, CRGX's receivables moved from $2.5M to $800K — a 68.1% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in CARGO Therapeutics's operating scale or balance-sheet position.

A receivables figure of $800K for CRGX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting CRGX's receivables ($800K), review year-over-year change from $2.5M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.